Epidemiology of central nervous system tumors in children
- Ching Lau, MD, PhD
Ching Lau, MD, PhD
- Chief, Hematology Oncology at Connecticut Children's Medical Center
- Professor at Jackson Laboratory for Genomic Medicine
- Head of Division of Pediatric Hematology-Oncology, University of Connecticut School of Medicine
- Wan-Yee Teo, MBBS, FAAP, MRCPCH (UK), PhD
Wan-Yee Teo, MBBS, FAAP, MRCPCH (UK), PhD
- Assistant Professor
- Duke-NUS Graduate Medical School
- Adjunct Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology
- Baylor College of Medicine
Central nervous system (CNS) tumors include both nonmalignant and malignant tumors of the brain and spinal cord. Primary malignant CNS tumors are the second most common childhood malignancies, after hematologic malignancies, and are the most common pediatric solid organ tumor (table 1) . Although progress has been made in the treatment of childhood tumors, significant mortality and morbidity are still associated with malignant brain tumors.
The epidemiology of CNS tumors in children will be reviewed here. The clinical manifestations, diagnosis, and overview of the management of CNS tumors and outcome in children are discussed separately. (See "Clinical manifestations and diagnosis of central nervous system tumors in children" and "Overview of the management of central nervous system tumors in children".)
In the United States, based upon data from the Central Brain Tumor Registry of the United States (CBTRUS), the estimated incidence of primary nonmalignant and malignant CNS tumors is 5.6 cases per 100,000 person-years for children and adolescents ≤19 years of age . The estimated ten-year survival rate for all primary CNS tumors is approximately 70 percent in patients ≤19 years of age, resulting in approximately 26,000 children living in the United States with a CNS tumor.
In the United States, CNS tumors are the most common solid tumors in children (table 1) and are the leading cause of cancer death in children 0 through 14 years [1,3]. CNS tumors account for approximately 20 percent of all childhood malignancies (table 1).
In Germany, the incidence of childhood CNS tumors is lower, with a reported rate of 2.6 per 100,000 children <15 years based on epidemiologic data from 1990 to 1999 .
- Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008; 112:416.
- Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. Neuro Oncol 2015; 17 Suppl 4:iv1.
- Ostrom QT, de Blank PM, Kruchko C, et al. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro Oncol 2015; 16 Suppl 10:x1.
- Kaatsch P, Rickert CH, Kühl J, et al. Population-based epidemiologic data on brain tumors in German children. Cancer 2001; 92:3155.
- Wilson PE, Oleszek JL, Clayton GH. Pediatric spinal cord tumors and masses. J Spinal Cord Med 2007; 30 Suppl 1:S15.
- Zhou D, Zhang Y, Liu H, et al. Epidemiology of nervous system tumors in children: a survey of 1,485 cases in Beijing Tiantan Hospital from 2001 to 2005. Pediatr Neurosurg 2008; 44:97.
- Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000, Bleyer A, O’Leary M, Barr R, Ries LAG (Eds), National Cancer Institute, NIH Pub. No. 06-5767, Bethesda, MD 2006.
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131:803.
- Allen JC, Siffert J, Hukin J. Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr Neurosurg 1998; 28:49.
- Taylor AJ, Little MP, Winter DL, et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 2010; 28:5287.
- Zhang J, Walsh MF, Wu G, et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med 2015; 373:2336.